A Study Assessing the Safety and Efficacy of Dextenza® for the Treatment of Ocular Pain and Inflammation Following Surgery for Pediatric Cataract
Trial details
- Registry ID
- NCT04539548
- Phase
- Phase 3
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Study Assessing the Safety and Efficacy of Dextenza® for the Treatment of Ocular Pain and Inflammation Following Surgery for Pediatric CataractNCT04539548 | OCUL | Phase 3 | Completed | 2023-12-21Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |